Developer docs
API playgroundTry for free, no card

Search company profiles

Alchem International

Full company profile

uuid000in21

Namestring
Alchem International
Legal namestring
Alchem International Pvt. Ltd.
Company typeenum
Private
Founded yearint
1951
Descriptiontext

Alchem International Pvt. Ltd. is a privately held, India-based manufacturer, supplier, and exporter of plant-derived active ingredients serving the pharmaceutical, cosmeceutical, and nutraceutical industries. Founded around 1951 and headquartered in New Delhi with operations across India, the USA, and the UK, the company self-describes 75 years of experience and a position as a pioneer in phytoceuticals — the science of using plant molecules for medicinal applications. Its product architecture spans standardized botanical extracts, pharmaceutical-grade APIs such as Digoxin (EP/USP) and Digoxin Micronized (EP) carrying CEP certifications and USDMF filings, and a newer Natural E-Cigarette Nicotine line positioned as a flagship offering.

The company's technological foundation is its proprietary PhytoAdvance platform, a phytochemical extraction technology used to develop standardized botanical ingredients for downstream pharmaceutical, cosmetic, and nutraceutical formulations. Manufacturing is vertically integrated 'from farm to pharmacy,' controlling raw material sourcing through finished actives. Alchem has cleared eight successive USFDA inspections (2009, 2012, 2014, 2016, 2017, 2019, 2024, 2026) and operates a downstream branded finished-dosage portfolio under the Pharmacy vertical covering nine SKUs (including MiraQule, Belic, ReQollect, FlexiQule, ProstaQuil, CalQuest, Liverubin, and the ThioQuest family). Sub-brands include Epique for cosmeceutical actives and PhytoAdvance as a standalone technology platform.

Alchem's revenue mechanics are B2B and sales-led, supplying APIs and standardized extracts directly to pharmaceutical, cosmetic, and nutraceutical manufacturers worldwide under quote-based pricing tied to volume and specification. Four revenue streams are defined: Pharmaceutical Actives, Cosmeceutical Actives, Nutraceutical Actives, and Nicotine Products. Distribution runs through direct enterprise sales supplemented by international trade show presence, with no consumer retail or digital channel. The company is privately held under Indian private limited company law, with no disclosed institutional investors, funding rounds, or management team in the source material; a separate entity, Alchemy International Ltd., was acquired by FDCTech in October 2025 and should not be conflated with Alchem International. Alchem faces an ongoing trademark dispute with Alkem Laboratories over the 'Alchem' name.

Short descriptiontext

Alchem International is a privately held New Delhi-based manufacturer and supplier of plant-derived active ingredients, serving pharmaceutical, cosmeceutical, and nutraceutical companies across India, the USA, and the UK through standardized botanical extracts, pharmaceutical-grade APIs, and branded finished health products.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
botanical extracts manufacturing, pharmaceutical active ingredients, phytochemical extracts supply, cosmeceutical actives supply, nutraceutical ingredients supply
Industry3 codes
PRIMARYAFAJADAC
Aroma Chemicals & Synthetic Flavor Ingredients (e.g., Vanillin, Esters, Aldehydes)
Agriculture & Food Production/Food Ingredients & Additives/Flavors & Flavor Enhancers (Natural/Artificial Flavors, Umami Enhancers)
SECONDARYCRADAJAG
E-liquids & Nicotine Salts Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
SECONDARYHLAGAHAD
Controlled Substances / DEA-Scheduled API Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Phytochemical / Botanical Active Ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceutical Actives
TypeOne Time License
Description

Supply of plant-based active pharmaceutical ingredients (APIs) to pharmaceutical companies for drug development and manufacturing.

alcheminternational.com
2Cosmeceutical Actives
TypeOne Time License
Description

Supply of botanical extracts and phytochemical ingredients to cosmetic and skincare brands.

alcheminternational.com
3Nutraceutical Actives
TypeOne Time License
Description

Supply of plant-based ingredients for nutraceutical and dietary supplement manufacturers.

alcheminternational.com
4Nicotine Products
TypeOne Time License
Description

Natural nicotine products for e-cigarettes and nicotine replacement applications.

alcheminternational.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1PhytoAdvance
Description

Alchem's proprietary phytochemical extracts technology platform, marketed as a distinct brand for standardized botanical ingredients.

alcheminternational.com
+10 more records
Core offering1 text field

Alchem International is a manufacturer and supplier of standardized plant-based active ingredients (phytoceuticals) for the pharmaceutical, cosmetic, and nutraceutical industries. The company produces pharmaceutical actives such as Digoxin, branded finished pharmaceutical formulations (MiraQule, Belic, ReQollect, ThioQuest line, etc.), cosmeceutical actives through its Epique sub-brand, and a natural nicotine product line for e-cigarette applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Alchem International is a B2B manufacturer and supplier of phytoceutical ingredients serving pharmaceutical, cosmeceutical, and nutraceutical industries. The company operates across three core divisions—Pharmaceutical Actives (including branded products like MiraQule, Belic, ReQollect, MiraQule C, FlexiQule, ProstaQuil, CalQuest, Liverubin, and the ThioQuest line of muscle relaxants), Cosmeceutical Actives (through the Epique sub-brand), and Nutraceutical Actives. Their technology differentiation rests on the proprietary PhytoAdvance platform for standardized botanical extracts, and they offer a dedicated Nicotine product line for e-cigarette applications. Core pharmaceutical ingredients include Digoxin (EP/USP) and Digoxin Micronized, both carrying CEP certifications. The company emphasizes vertical integration from farm to pharmacy and claims 75 years of experience in developing natural health solutions.

Product and service18 records
1MiraQule
CategoryPharmaceutical finished product
Description

Coenzyme Q10 capsules (50mg, 100mg, and 200mg) marketed as 'The Cellular Energizer' for age and fatigue care.

2Belic
CategoryPharmaceutical finished product
Description

Anti-spasmodic and analgesic tablets combining Hyoscine Butyl Bromide and Paracetamol, positioned for abdominal care.

3ReQollect
CategoryPharmaceutical finished product
Description

Vinpocetine capsules marketed as 'The Memory Sharpner' for brain care applications.

4MiraQule C
CategoryPharmaceutical finished product
Description

Coenzyme Q10 and Grape Seed Phyto Extract capsule marketed as 'A Heart Energizer' for cardio care.

5FlexiQule
CategoryPharmaceutical finished product
Description

Boswellia Phyto Extract capsule positioned to reduce joint pain and inflammation, for joint care.

6ProstaQuil
CategoryPharmaceutical finished product
Description

Combination supplement with Pygeum Extract, Saw Palmetto Oil, Zinc Oxide and Pumpkin Seed Oil marketed as 'The Ultimate Prostate Guard'.

7CalQuest
CategoryPharmaceutical finished product
Description

Coral Calcium, Soya Isoflavone, Natural Calcitriol and Boron formulation marketed as 'The 24 Hour Bone Bank' for woman care.

8Liverubin
CategoryPharmaceutical finished product
Description

Water-soluble Silymarin supplement (70mg and 140mg) marketed as 'The Ultimate Liver Shield' for liver care.

9ThioQuest 4mg/8mg
CategoryPharmaceutical finished product
Description

Thiocolchicoside muscle relaxant and pain reliever with sublingual delivery for ortho care.

10ThioQuest D4/D8
CategoryPharmaceutical finished product
Description

Combination of Thiocolchicoside and Diclofenac for pain management.

11ThioQuest DP4/DP8
CategoryPharmaceutical finished product
Description

Triple combination of Thiocolchicoside, Paracetamol and Diclofenac for relieving pain and spasms.

12ThioQuest ET4
CategoryPharmaceutical finished product
Description

Combination of Thiocolchicoside and Etoricoxib for joint pain and spasms.

13ThioQuest Gel
CategoryPharmaceutical finished product
Description

Topical formulation combining Thiocolchicoside and Diclofenac for topical pain relief.

14Digoxin (EP/USP)
CategoryPharmaceutical active ingredient (API)
Description

Pharmaceutical-grade Digoxin compliant with European Pharmacopeia and United States Pharmacopeia; CEP # R1-CEP-2012-194-Rev.00. Supplied as an API to pharmaceutical companies.

15Digoxin Micronized (EP)
CategoryPharmaceutical active ingredient (API)
Description

Micronized Digoxin formulation meeting European Pharmacopeia standards; CEP # R1-CEP-2016-234-Rev.00. Supplied as an API to pharmaceutical companies.

16Natural E-Cigarette Nicotine
CategoryPharmaceutical / nicotine product
Description

Natural nicotine product with superior stability and flavor characteristics, supplied for e-cigarette and nicotine replacement applications; described as a blockbuster product.

17PhytoAdvance
CategoryProprietary technology platform / brand
Description

Alchem's proprietary phytochemical extracts technology platform for developing standardized botanical ingredients across pharmaceutical, cosmetic, and nutraceutical applications.

18Epique
CategoryCosmeceutical actives sub-brand
Description

Cosmeceutical actives sub-brand offering botanical ingredients for cosmetic and skincare applications.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Martin Bauer Group
TypeDirect peer
Description

German-headquartered global supplier of botanical extracts, tea, and plant-based ingredients to pharmaceutical, food, and beverage industries. Comparable vertically-integrated sourcing model and standardized extract portfolio.

TypeBroad incumbent
Description

India-based broad-spectrum pharmaceutical manufacturer with branded generics across multiple therapeutic areas. Comparable Indian pharma footprint and therapeutic categories overlapping Alchem's finished-dose portfolio; the trademark dispute adds a direct competitive overlap.

TypeDirect peer
Description

US-based manufacturer of standardized botanical extracts and cosmeceutical/nutraceutical actives. Direct peer to Alchem in supplying branded, IP-protected plant-based ingredients to global pharma and personal care customers.

4Naturex (Givaudan)
TypeBroad incumbent
Description

France-based, now part of Givaudan, supplying natural ingredients for food, nutrition, and personal care. Comparable botanical extract portfolio and customer base, but operates as a much larger diversified ingredient platform rather than a specialized phytoceuticals player.

TypeEmerging player
Description

US-based supplier of standardized botanical extracts and nutritional raw materials. Comparable focus on standardized plant-derived ingredients for nutraceutical and functional food applications, though smaller and more US-centric.

TypeDirect peer
Description

Italian-headquartered global leader in botanical active ingredients for pharmaceutical, nutraceutical, and cosmetic applications. Directly comparable to Alchem as a vertically-integrated, standardized botanical extract supplier serving the same pharma and cosmeceutical customer base.

TypeDirect peer
Description

India-based manufacturer of spice extracts, oleoresins, and standardized botanical ingredients for pharma, nutraceutical, and flavor applications. Direct peer as an Indian-origin global botanical extract supplier.

TypeDirect peer
Description

Spanish producer of standardized botanical extracts for pharmaceutical, nutraceutical, and cosmetic industries. Directly comparable in proprietary extraction technology, regulatory dossiers, and customer segments.

TypeRegional player
Description

India-based manufacturer of natural ingredient extracts and flavors for food, beverage, and personal care industries. Comparable regional botanical extraction capabilities serving overlapping Indian and export customers.

TypeRegional player
Description

Brazilian botanical extract manufacturer serving pharmaceutical, nutraceutical, and cosmetic industries. Comparable standardized botanical extract offering but concentrated in the South American market rather than Alchem's India/US/UK footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alchem International

Phytochemical / Botanical Active Ingredientsalcheminternational.com

Alchem International is a privately held New Delhi-based manufacturer and supplier of plant-derived active ingredients, serving pharmaceutical, cosmeceutical, and nutraceutical companies across India, the USA, and the UK through standardized botanical extracts, pharmaceutical-grade APIs, and branded finished health products.

What Alchem International does

Alchem International Pvt. Ltd. is a privately held, India-based manufacturer, supplier, and exporter of plant-derived active ingredients serving the pharmaceutical, cosmeceutical, and nutraceutical industries. Founded around 1951 and headquartered in New Delhi with operations across India, the USA, and the UK, the company self-describes 75 years of experience and a position as a pioneer in phytoceuticals — the science of using plant molecules for medicinal applications. Its product architecture spans standardized botanical extracts, pharmaceutical-grade APIs such as Digoxin (EP/USP) and Digoxin Micronized (EP) carrying CEP certifications and USDMF filings, and a newer Natural E-Cigarette Nicotine line positioned as a flagship offering.

The company's technological foundation is its proprietary PhytoAdvance platform, a phytochemical extraction technology used to develop standardized botanical ingredients for downstream pharmaceutical, cosmetic, and nutraceutical formulations. Manufacturing is vertically integrated 'from farm to pharmacy,' controlling raw material sourcing through finished actives. Alchem has cleared eight successive USFDA inspections (2009, 2012, 2014, 2016, 2017, 2019, 2024, 2026) and operates a downstream branded finished-dosage portfolio under the Pharmacy vertical covering nine SKUs (including MiraQule, Belic, ReQollect, FlexiQule, ProstaQuil, CalQuest, Liverubin, and the ThioQuest family). Sub-brands include Epique for cosmeceutical actives and PhytoAdvance as a standalone technology platform.

Alchem's revenue mechanics are B2B and sales-led, supplying APIs and standardized extracts directly to pharmaceutical, cosmetic, and nutraceutical manufacturers worldwide under quote-based pricing tied to volume and specification. Four revenue streams are defined: Pharmaceutical Actives, Cosmeceutical Actives, Nutraceutical Actives, and Nicotine Products. Distribution runs through direct enterprise sales supplemented by international trade show presence, with no consumer retail or digital channel. The company is privately held under Indian private limited company law, with no disclosed institutional investors, funding rounds, or management team in the source material; a separate entity, Alchemy International Ltd., was acquired by FDCTech in October 2025 and should not be conflated with Alchem International. Alchem faces an ongoing trademark dispute with Alkem Laboratories over the 'Alchem' name.

Alchem International firmographics

Firmographics
Name
Alchem International
Legal name
Alchem International Pvt. Ltd.
Website
https://alcheminternational.com
Company type
Private
Founded year
1951
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Alchem International is a privately held New Delhi-based manufacturer and supplier of plant-derived active ingredients, serving pharmaceutical, cosmeceutical, and nutraceutical companies across India, the USA, and the UK through standardized botanical extracts, pharmaceutical-grade APIs, and branded finished health products.
Ownership category
akta.pro rank

Alchem International industry classification

Industry
Product category
Phytochemical / Botanical Active Ingredients
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYAFAJADAC
Aroma Chemicals & Synthetic Flavor Ingredients (e.g., Vanillin, Esters, Aldehydes)
Agriculture & Food Production/Food Ingredients & Additives/Flavors & Flavor Enhancers (Natural/Artificial Flavors, Umami Enhancers)
SECONDARYCRADAJAG
E-liquids & Nicotine Salts Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
SECONDARYHLAGAHAD
Controlled Substances / DEA-Scheduled API Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Botanical extracts manufacturing
  • Pharmaceutical active ingredients
  • Phytochemical extracts supply
  • Cosmeceutical actives supply
  • Nutraceutical ingredients supply

Where Alchem International is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Alchem International business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Actives: Supply of plant-based active pharmaceutical ingredients (APIs) to pharmaceutical companies for drug development and manufacturing.
  2. Cosmeceutical Actives: Supply of botanical extracts and phytochemical ingredients to cosmetic and skincare brands.
  3. Nutraceutical Actives: Supply of plant-based ingredients for nutraceutical and dietary supplement manufacturers.
  4. Nicotine Products: Natural nicotine products for e-cigarettes and nicotine replacement applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Alchem International product offering

Product offering

Core offering

Alchem International is a manufacturer and supplier of standardized plant-based active ingredients (phytoceuticals) for the pharmaceutical, cosmetic, and nutraceutical industries. The company produces pharmaceutical actives such as Digoxin, branded finished pharmaceutical formulations (MiraQule, Belic, ReQollect, ThioQuest line, etc.), cosmeceutical actives through its Epique sub-brand, and a natural nicotine product line for e-cigarette applications.

Product overview

Alchem International is a B2B manufacturer and supplier of phytoceutical ingredients serving pharmaceutical, cosmeceutical, and nutraceutical industries. The company operates across three core divisions—Pharmaceutical Actives (including branded products like MiraQule, Belic, ReQollect, MiraQule C, FlexiQule, ProstaQuil, CalQuest, Liverubin, and the ThioQuest line of muscle relaxants), Cosmeceutical Actives (through the Epique sub-brand), and Nutraceutical Actives. Their technology differentiation rests on the proprietary PhytoAdvance platform for standardized botanical extracts, and they offer a dedicated Nicotine product line for e-cigarette applications. Core pharmaceutical ingredients include Digoxin (EP/USP) and Digoxin Micronized, both carrying CEP certifications. The company emphasizes vertical integration from farm to pharmacy and claims 75 years of experience in developing natural health solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • PhytoAdvance: Alchem's proprietary phytochemical extracts technology platform, marketed as a distinct brand for standardized botanical ingredients.
  • Epique
  • MiraQule
  • MiraQule C
  • Belic
  • ReQollect
  • FlexiQule
  • ProstaQuil
  • CalQuest
  • Liverubin
  • ThioQuest

Products and services

  • MiraQule Coenzyme Q10 capsules (50mg, 100mg, and 200mg) marketed as 'The Cellular Energizer' for age and fatigue care.
  • Belic Anti-spasmodic and analgesic tablets combining Hyoscine Butyl Bromide and Paracetamol, positioned for abdominal care.
  • ReQollect Vinpocetine capsules marketed as 'The Memory Sharpner' for brain care applications.
  • MiraQule C Coenzyme Q10 and Grape Seed Phyto Extract capsule marketed as 'A Heart Energizer' for cardio care.
  • FlexiQule Boswellia Phyto Extract capsule positioned to reduce joint pain and inflammation, for joint care.
  • ProstaQuil Combination supplement with Pygeum Extract, Saw Palmetto Oil, Zinc Oxide and Pumpkin Seed Oil marketed as 'The Ultimate Prostate Guard'.
  • CalQuest Coral Calcium, Soya Isoflavone, Natural Calcitriol and Boron formulation marketed as 'The 24 Hour Bone Bank' for woman care.
  • Liverubin Water-soluble Silymarin supplement (70mg and 140mg) marketed as 'The Ultimate Liver Shield' for liver care.
  • ThioQuest 4mg/8mg Thiocolchicoside muscle relaxant and pain reliever with sublingual delivery for ortho care.
  • ThioQuest D4/D8 Combination of Thiocolchicoside and Diclofenac for pain management.
  • ThioQuest DP4/DP8 Triple combination of Thiocolchicoside, Paracetamol and Diclofenac for relieving pain and spasms.
  • ThioQuest ET4 Combination of Thiocolchicoside and Etoricoxib for joint pain and spasms.
  • ThioQuest Gel Topical formulation combining Thiocolchicoside and Diclofenac for topical pain relief.
  • Digoxin (EP/USP) Pharmaceutical-grade Digoxin compliant with European Pharmacopeia and United States Pharmacopeia; CEP # R1-CEP-2012-194-Rev.00. Supplied as an API to pharmaceutical companies.
  • Digoxin Micronized (EP) Micronized Digoxin formulation meeting European Pharmacopeia standards; CEP # R1-CEP-2016-234-Rev.00. Supplied as an API to pharmaceutical companies.
  • Natural E-Cigarette Nicotine Natural nicotine product with superior stability and flavor characteristics, supplied for e-cigarette and nicotine replacement applications; described as a blockbuster product.
  • PhytoAdvance Alchem's proprietary phytochemical extracts technology platform for developing standardized botanical ingredients across pharmaceutical, cosmetic, and nutraceutical applications.
  • Epique Cosmeceutical actives sub-brand offering botanical ingredients for cosmetic and skincare applications.

Companies that use Alchem International

Customer profile

Segments4 records

Ideal customer profiles4 records

Alchem International technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Alchem International partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Alchem International competitors and assessment

Company assessment

Direct peers

  • Martin Bauer Group: German-headquartered global supplier of botanical extracts, tea, and plant-based ingredients to pharmaceutical, food, and beverage industries. Comparable vertically-integrated sourcing model and standardized extract portfolio.
  • Sabinsa Corporation: US-based manufacturer of standardized botanical extracts and cosmeceutical/nutraceutical actives. Direct peer to Alchem in supplying branded, IP-protected plant-based ingredients to global pharma and personal care customers.
  • Indena S.p.A. Italian-headquartered global leader in botanical active ingredients for pharmaceutical, nutraceutical, and cosmetic applications. Directly comparable to Alchem as a vertically-integrated, standardized botanical extract supplier serving the same pharma and cosmeceutical customer base.
  • Synthite Industries: India-based manufacturer of spice extracts, oleoresins, and standardized botanical ingredients for pharma, nutraceutical, and flavor applications. Direct peer as an Indian-origin global botanical extract supplier.
  • Euromed S.A. Spanish producer of standardized botanical extracts for pharmaceutical, nutraceutical, and cosmetic industries. Directly comparable in proprietary extraction technology, regulatory dossiers, and customer segments.

Broad incumbents

  • Alkem Laboratories: India-based broad-spectrum pharmaceutical manufacturer with branded generics across multiple therapeutic areas. Comparable Indian pharma footprint and therapeutic categories overlapping Alchem's finished-dose portfolio; the trademark dispute adds a direct competitive overlap.
  • Naturex (Givaudan): France-based, now part of Givaudan, supplying natural ingredients for food, nutrition, and personal care. Comparable botanical extract portfolio and customer base, but operates as a much larger diversified ingredient platform rather than a specialized phytoceuticals player.

Emerging players

  • Cepham Inc. US-based supplier of standardized botanical extracts and nutritional raw materials. Comparable focus on standardized plant-derived ingredients for nutraceutical and functional food applications, though smaller and more US-centric.

Regional players

  • Kancor Ingredients: India-based manufacturer of natural ingredient extracts and flavors for food, beverage, and personal care industries. Comparable regional botanical extraction capabilities serving overlapping Indian and export customers.
  • Herbarium: Brazilian botanical extract manufacturer serving pharmaceutical, nutraceutical, and cosmetic industries. Comparable standardized botanical extract offering but concentrated in the South American market rather than Alchem's India/US/UK footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Alchem International social profiles

Digital presence

Alchem International compliance and trust

Trust signal

Compliance2 records

Alchem International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alchem International leadership team

Management profile

Number of profiles

Profiles1 record

Alchem International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alchem International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alchem International

What does Alchem International do?

Alchem International is a manufacturer and supplier of standardized plant-based active ingredients (phytoceuticals) for the pharmaceutical, cosmetic, and nutraceutical industries. The company produces pharmaceutical actives such as Digoxin, branded finished pharmaceutical formulations (MiraQule, Belic, ReQollect, ThioQuest line, etc.), cosmeceutical actives through its Epique sub-brand, and a natural nicotine product line for e-cigarette applications.

Is Alchem International a public or private company?

Alchem International is a private company. It is classified as unknown and is currently operating.

When was Alchem International founded?

Alchem International was founded in 1951. It employs 501 to 1,000 people.

Where is Alchem International based?

Alchem International is headquartered in New Delhi, India, in the Asia region.

How does Alchem International make money?

Four revenue lines are on record. Pharmaceutical Actives are the primary driver. The others are cosmeceutical Actives, nutraceutical Actives and nicotine Products.

Who are Alchem International's main competitors?

Direct peers on record are Martin Bauer Group, Sabinsa Corporation, Indena S.p.A., Synthite Industries and Euromed S.A.. Broad incumbents are Alkem Laboratories and Naturex (Givaudan). Cepham Inc. is listed as an emerging player. Regional players are Kancor Ingredients and Herbarium.

Does Alchem International have an API?

No public API is recorded for Alchem International.

What industry is Alchem International in?

Alchem International's product category is Phytochemical / Botanical Active Ingredients. Its primary akta.pro industry code is AFAJADAC, Aroma Chemicals & Synthetic Flavor Ingredients (e.g., Vanillin, Esters, Aldehydes), with a secondary code of CRADAJAG, E-liquids & Nicotine Salts Manufacturing & Brands. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pegnCade condena farmacêuticas por cartel internacionalBrazil's Cade fined four pharmaceutical companies and three individuals for an international cartel in antispasmodic drug production. Fines totaled R$4.184 million for Alchem International, R$10 million for Alkaloids of Australia, and R$2.428 million for Vital Laboratories, with additional penalties for individuals. The cartel, involving escopolamine, operated from 1989 to at least 2019.Market Research & Business IntelligencePlant Based API MarketThe global plant-based Active Pharmaceutical Ingredient (API) market is projected to grow from USD 4.2 billion in 2026 to USD 7.8 billion by 2036, representing a 6.4% CAGR, driven by regulatory support for natural compounds and rising demand for complex therapeutic molecules in oncology and chronic disease management. Amino acids lead product segments with 43.2% market share, while pharmaceuticals represent the largest application segment at 52.1%, reflecting the structural shift toward standardized botanical ingredients in drug development. Key growth markets include India (8.7% CAGR), China (7.2% CAGR), Germany (6.8% CAGR), USA (6.1% CAGR), and Brazil (5.9% CAGR), with leading players including Alchem International Ltd., Indena S.p.A., Naturex SA, DSM Nutritional Products, and Biocon Limited.The Times of IndiaAlchem International moves Delhi HC against single-judge order on ‘Alchem’ trademark - The Economic TimesAlchem International challenged a single-judge order at the Delhi High Court division bench that restrains it from selling pharmaceutical products under the name 'Alchem' due to similarity with Alkem Laboratories' registered trademark 'Alkem'. The court found the two marks phonetically identical and visually/structurally similar, ruling in favor of Alkem which has used its trademark since 1973 versus Alchem's 1985 usage without registration. Alchem can continue manufacturing and selling active pharmaceutical ingredients (APIs) but not for retail sales in India, and the case will be heard further on Friday.PR NewswireAlchem International löst Stabilitätsdilemma für mikronisiertes Digoxin und meldet einen neuartigen Produktionsprozess zum Patent anAlchem International has launched a proprietary platform for micronized Digoxin, solving the stability and impurity challenges that had previously limited shelf life to 12–24 months, and has filed a patent application for its innovative production process. The company's facility in Ballabhgarh, India, received inspection and approval from ANSM on behalf of EDQM, enabling it to supply the drug with a claimed stability profile of one year at room temperature and four years under refrigeration. This development addresses a supply gap since Boehringer Ingelheim discontinued production of micronized Digoxin in 2014.PR NewswireAlchem International soluciona el dilema de la estabilidad de la digoxina micronizadaAlchem International, a private pharmaceutical company specializing in plant-derived active pharmaceutical ingredients (APIs), announced the launch of its proprietary micronized digoxin platform and filed a patent for the new production process. The company's innovation addresses a long-standing stability challenge that had limited the shelf life of micronized digoxin to just 12-24 months and caused impurity formation, filling a supply gap created when Boehringer Ingelheim discontinued production in 2014. The micronized digoxin meets European Pharmacopoeia standards, carries a European Certificate of Suitability from EDQM, and is manufactured at Alchem's facility in Ballabhgarh, India, which received regulatory approval from ANSM on behalf of EDQM.PR NewswireAlchem International recibe el Certificado Europeo de SostenibilidadAlchem International received the European Certificate of Suitability (CES) from EDQM for its patented production process for micronized digoxin, which addresses stability and formulation challenges. The process achieves optimal particle size distribution, enabling stable storage for one year at room temperature and three years under refrigeration, with stability studies suggesting a five-year shelf life.PR NewswireAlchem International Granted COS by EDQM for Innovative Production Process to Resolve Stability Challenge for Micronized DigoxinAlchem International received a European Certificate of Suitability (COS) from EDQM for its patented production process for micronized digoxin, which addresses stability and formulation challenges. The process achieves an optimum particle size distribution, enabling stable storage for one year at ambient temperatures and three years under cold storage, with shelf life expected to extend to five years.